- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02674464
Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project) (RICH LIFE)
Comparative Effectiveness of Health System vs. Multilevel Interventions to Reduce Hypertension Disparities
Study Overview
Status
Conditions
Intervention / Treatment
- Behavioral: Provider Audit-Feedback, Stratified by Race and Ethnicity
- Behavioral: Blood Pressure Measurement Standardization
- Behavioral: System Level Leadership Intervention
- Behavioral: Collaborative Care Team Intervention
- Behavioral: Community Health Worker Referral
- Behavioral: Specialist Care Consultation
Detailed Description
The investigators refined research aim is to determine if a clinic-based collaborative care team, including a community health worker (CHW) to deliver community-based contextualized care, reduces disparities in blood pressure control rates, lowers cardiovascular disease (CVD) risk, and improves outcomes among patients with hypertension and other common comorbid conditions when compared to standard of care health system approaches to CVD risk management, including audit and feedback and staff and provider training.
Collaborative care includes care coordination and care management; regular and proactive monitoring and treatment to target specific patient needs using validated clinical tools and rating scales; and regular systematic caseload reviews by the care team and consultation with experts for patients who do not show clinical improvement. A typical collaborative care team includes the primary care provider, nurse care manager or coordinator, and other members of the clinic staff involved in patient care.
Intervention protocols are designed to address common comorbidities (diabetes, hyperlipidemia, depression and coronary heart disease), lifestyle factors (dietary intake, physical activity, and smoking) and medication adherence. The intensive intervention treats the "whole" patient, driven by individual patient goals and priorities, as opposed to the standard of care, which typically focuses on individual conditions. This proposed study responds directly to patient desires to feel more equipped to be involved in their care and manage multiple conditions that contribute to CVD. The investigators have worked successfully in the past with a broad range of stakeholders, including community members, patients, providers, and payors, and will continue to engage them through the research and dissemination process.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients (≥21 years of age) obtaining primary care from a provider at a participating practice
A diagnosis of hypertension or SBP≥140mmHg or DBP≥90mmHg twice in the past year or on antihypertensive medications plus at least one of the following CVD risk factors:
- Diabetes mellitus (fasting blood sugar> 125mg/dl or hemoglobin A1c>6.5 or on a hypoglycemic medication);
- Dyslipidemia (LDL >130 mg/dl, HDL<40 or total cholesterol >200 or on a lipid lowering agent);
- Coronary heart disease
- Current tobacco smokers
- Depression by International Classification of Disease, 9th edition (ICD-9), codes or Patient Health Questionnaire (PHQ) score >9
Exclusion Criteria:
- Cardiovascular event (unstable angina, myocardial infarction) within the past 6 months
- Serious medical condition which either limits life expectancy or requires active management (e.g., certain cancers)
- Condition which interferes with outcome measurement (e.g., dialysis)
- Pregnant or planning a pregnancy during study period. Nursing mothers would need approval from physician.
- Alcohol or substance use disorder if not sober/abstinent for ≥30 days
- Planning to leave clinic within 6 months or move out of geographic area within 18 months
- Individuals with cognitive impairment or other condition which makes them unable to participate in the intervention
- Participating in another lifestyle modification, weight reduction, or treatment trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Standard of Care Plus
The standard of care plus arm will include audit and feedback of blood pressure control rates at the provider level along with web-based training about: 1) barriers to blood pressure and cardiovascular disease (CVD) risk factors management in at-risk patient populations; 2) strategies to address healthcare disparities in clinical settings; and 3) appropriate blood pressure (BP) measurement techniques for all clinical staff.
The Hopkins research team will help clinics develop audit and feedback mechanisms if they are lacking and will provide all blood pressure measurement and web-based training.
|
Transparent and timely access to and review of clinical performance data are among the key elements of successful improvement activities.
The RICH LIFE Project provides the health systems with the logic to build practice and provider level hypertension (HTN) dashboards, support in building the dashboard, and education in utilizing the dashboard.
The practice dashboard provides a display of the percentage of patients achieving BP control, defined as <140/90 mm Hg for the overall practice, while the provider dashboard provides a display of the percentage of patients achieving BP control for each provider's patient panel.
Both the practice and provider Dashboards stratify hypertension performance data by race (White, non-Hispanic; Black, non-Hispanic; and All Hispanic) to help practice administration and clinicians evaluate differences between races and ethnicities in BP control rates.
New reports are generated at least quarterly and will display data from the previous 3 months.
Other Names:
All adult medicine staff at participating study practices receive standardized, evidence-based, best practices BP measurement training.
Aspects of the training include proper patient preparation and positioning, how use of an automated BP measurement device, and executing a "screen and confirm" protocol when measuring patients' blood pressures.
|
|
EXPERIMENTAL: Collaborative Care/Stepped Care (CC/SC)
The CC/SC arm includes: -BP training -Audit and feedback dashboard, data stratified by race, ethnicity, payor status -A 4 hour workshop for organizational leaders in quality improvement and disparities reduction, with follow up meetings for problem-solving and support, and web-based, patient-centered communication skills training program for providers and staff -Support and guidance in establishing collaborative care model (CCM): team-based care targeting health behaviors and medication adherence.
The primary care provider (PCP), care manager, CHW, and specialists in: medication management, psychosocial/behavioral, and self-management will make up the CCM team -Community health workers (CHW) working on contextualized patient interactions focused on problem-solving skills and patient self-management.
CHWs will visit their patients in their homes and communities -Provider access to on-call specialists for help with patients who do not achieve BP control under the CC/SC
|
Transparent and timely access to and review of clinical performance data are among the key elements of successful improvement activities.
The RICH LIFE Project provides the health systems with the logic to build practice and provider level hypertension (HTN) dashboards, support in building the dashboard, and education in utilizing the dashboard.
The practice dashboard provides a display of the percentage of patients achieving BP control, defined as <140/90 mm Hg for the overall practice, while the provider dashboard provides a display of the percentage of patients achieving BP control for each provider's patient panel.
Both the practice and provider Dashboards stratify hypertension performance data by race (White, non-Hispanic; Black, non-Hispanic; and All Hispanic) to help practice administration and clinicians evaluate differences between races and ethnicities in BP control rates.
New reports are generated at least quarterly and will display data from the previous 3 months.
Other Names:
All adult medicine staff at participating study practices receive standardized, evidence-based, best practices BP measurement training.
Aspects of the training include proper patient preparation and positioning, how use of an automated BP measurement device, and executing a "screen and confirm" protocol when measuring patients' blood pressures.
This System-Level Leadership intervention aims to create a learning network through an inter-organizational approach to promote health equity and reduce CVD disparities.
Elements of the system-level leadership intervention, then, include: 1) an introductory session during the kick-off event (baseline); 2) a quarterly 1 hour "content call" with a presentation on leading for equity and discussion among system-level leaders, community organization leaders, and interested practice champions in the CC/Stepped care arm conducted via conference call/webinar; and 3) monthly "coaching calls" for the system and practice level leaders, CMs, and CHWs in the CC/stepped care arm to discuss the interventions, while they are actively engaged in the intervention phase.
The collaborative care intervention creates a collaborative care team that, at a minimum, consists of PCP, nurse, or social worker care manager, and community health worker.
The collaborative care team develops the medical management plan in partnership with patients; 2) uses care coordination to maximize interaction of the patients' PCPs with other care providers addressing medication management, patient self-management, and psychosocial support on a regular, consistent basis; and 3) determines patient access to CHW support and subspecialty consultations.
Other Names:
As a "stepped up" component of the Collaborative Care Team Intervention for patients needing support in overcoming a variety of social determinants
As a "stepped up" component of the Collaborative Care Team Intervention for patients with complex medical conditions and/or patients that may not typically have access to specialist care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Controlled Blood Pressure
Time Frame: 12 months
|
Number of participants with Controlled Blood Pressure (<140/90 mm Hg).
|
12 months
|
|
Patient Activation Measure (PAM-13)
Time Frame: Baseline, 12 months
|
The Patient Activation Measure assesses knowledge, skills, and confidence in the management of one's health.
It is comprised of 13 items and each item is on a 1-5 scale.
Insignia health scores on a standardized overall score of 0-100 where higher scores indicate a better outcome.
|
Baseline, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Systolic Blood Pressure
Time Frame: Baseline, 12 months
|
Mean Systolic Blood Pressure in mm Hg at baseline and 12 months.
|
Baseline, 12 months
|
|
Mean Diastolic Blood Pressure
Time Frame: Baseline, 12 months
|
Mean Diastolic Blood Pressure in mm Hg at baseline and 12 months.
|
Baseline, 12 months
|
|
Change in Global Framingham Risk Score
Time Frame: Baseline, 12, 24 months
|
Clinical Outcome
|
Baseline, 12, 24 months
|
|
Change in Mean Total Cholesterol (mg/dL)
Time Frame: Baseline, 12, 24 months
|
Clinical Outcome
|
Baseline, 12, 24 months
|
|
Change in Mean LDL-C (mg/dL)
Time Frame: Baseline, 12, 24 months
|
Clinical Outcome
|
Baseline, 12, 24 months
|
|
Change in Mean HDL (mg/dL)
Time Frame: Baseline, 12, 24 months
|
Clinical Outcome
|
Baseline, 12, 24 months
|
|
% With Controlled Total Cholesterol
Time Frame: Baseline
|
Clinical Outcome
|
Baseline
|
|
% With Controlled Total Cholesterol
Time Frame: 12 months
|
Clinical Outcome
|
12 months
|
|
% With Controlled Total Cholesterol
Time Frame: 24 months
|
Clinical Outcome
|
24 months
|
|
Change in Mean Glycosylated Hemoglobin (Hemoglobin A1c)
Time Frame: Baseline, 12, 24 months
|
Clinical Outcome
|
Baseline, 12, 24 months
|
|
% With Hemoglobin A1c< 7.0
Time Frame: Baseline
|
Clinical Outcome
|
Baseline
|
|
% With Hemoglobin A1c< 7.0
Time Frame: 12 months
|
Clinical Outcome
|
12 months
|
|
% With Hemoglobin A1c< 7.0
Time Frame: 24 months
|
Clinical Outcome
|
24 months
|
|
Change in Patient Assessment of Care for Chronic Conditions (PACIC-Plus)
Time Frame: Baseline, 12, 24 months
|
Patient Reported Outcome
|
Baseline, 12, 24 months
|
|
% With BP <140/90 mmHg
Time Frame: 24 months
|
Clinical Outcome
|
24 months
|
|
% With BP <130/80 mmHg
Time Frame: 12 months
|
Clinical Outcome
|
12 months
|
|
% With BP <130/80 mmHg
Time Frame: 24 months
|
Clinical Outcome
|
24 months
|
|
% With BP <120/80 mmHg
Time Frame: 12 months
|
Clinical Outcome
|
12 months
|
|
% With BP <120/80 mmHg
Time Frame: 24 months
|
Clinical Outcome
|
24 months
|
|
Change in Medication Adherence 4-Item Scale
Time Frame: Baseline, 12, 24 months
|
Patient Reported Outcome
|
Baseline, 12, 24 months
|
|
Change in Depressive Symptoms Patient Health Questionnaire (PHQ) 8 Score
Time Frame: Baseline 12, 24 months
|
Patient Reported Outcome
|
Baseline 12, 24 months
|
|
Change in Patient Ratings of Trust
Time Frame: Baseline, 12, 24 months
|
Patient Reported Outcome
|
Baseline, 12, 24 months
|
|
Change in Hypertension Knowledge and Attitudes
Time Frame: Baseline, 12, 24 months
|
Patient Reported Outcome
|
Baseline, 12, 24 months
|
|
Change in Health Related Quality of Life (PROMIS Global Scale)
Time Frame: Baseline, 12, 24 months
|
Patient Reported Outcome
|
Baseline, 12, 24 months
|
|
Change in Patient Attainment of Self-Defined Goals
Time Frame: Baseline, 12, 24 months
|
Patient Reported Outcome
|
Baseline, 12, 24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lisa Cooper, MD, MPH, Johns Hopkins University
- Principal Investigator: Jill Marsteller, PhD, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
General Publications
- Alvarez C, Ibe C, Dietz K, Carrero ND, Avornu G, Turkson-Ocran RA, Bhattarai J, Crews D, Lipman PD, Cooper LA; RICH LIFE Project Investigators. Development and Implementation of a Combined Nurse Care Manager and Community Health Worker Training Curriculum to Address Hypertension Disparities. J Ambul Care Manage. 2022 Jul-Sep 01;45(3):230-241. doi: 10.1097/JAC.0000000000000422.
- Cooper LA, Marsteller JA, Carson KA, Dietz KB, Boonyasai RT, Alvarez C, Ibe CA, Crews DC, Yeh HC, Miller ER 3rd, Dennison-Himmelfarb CR, Lubomski LH, Purnell TS, Hill-Briggs F, Wang NY; RICH LIFE Project Investigators. The RICH LIFE Project: A cluster randomized pragmatic trial comparing the effectiveness of health system only vs. health system Plus a collaborative/stepped care intervention to reduce hypertension disparities. Am Heart J. 2020 Aug;226:94-113. doi: 10.1016/j.ahj.2020.05.001. Epub 2020 May 8.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00085630
- UH3HL130688 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uncontrolled Hypertension
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingUncontrolled Hypertension
-
Colleen J KleinEnrolling by invitationUncontrolled HypertensionUnited States
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingUncontrolled HypertensionChina
-
Heart Center Leipzig - University HospitalActive, not recruitingArterial Hypertension | Uncontrolled HypertensionGermany
-
AstraZenecaCompleted
-
Shanghai Golden Leaf MedTec Co. LtdEuropean Cardiovascular Research CenterWithdrawnUncontrolled HypertensionSwitzerland
-
CVRx, Inc.Suspended
-
Verve Medical, IncClinical Accelerator (CRO); Israeli-Georgian Medical Research Clinic Helsicore and other collaboratorsActive, not recruitingHypertension | Uncontrolled HypertensionGeorgia
-
Abbott Medical DevicesCompletedUncontrolled HypertensionSpain, Belgium, Estonia, Italy, Portugal, United Kingdom
-
Medtronic VascularCompletedUncontrolled HypertensionUnited States
Clinical Trials on Provider Audit-Feedback, Stratified by Race and Ethnicity
-
University of ChicagoNorthwestern University; Ann & Robert H Lurie Children's Hospital of Chicago; Howard Brown Health Center and other collaboratorsCompleted
-
KU LeuvenCompletedHeart FailureBelgium
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPapillomavirus VaccinesUnited States
-
San Diego State UniversityNational Institute on Minority Health and Health Disparities (NIMHD); Family...RecruitingLow Back Pain | Neck PainUnited States
-
Indiana UniversityMedical University of South Carolina; National Institute of Diabetes and Digestive... and other collaboratorsRecruiting